Tacrolimus* — Medicare Part D Spending

Generic: Tacrolimus | Manufacturer: Overall

2023 Spending

$103.3M

2023 Claims

535,062

2023 Beneficiaries

204,385

Cost/Unit (2023)

$2.21

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	$75.2M	372,291	119,454	$2.28
2020	$104.5M	448,510	133,950	$2.38
2021	$101.8M	468,258	155,736	$2.28
2022	$107.1M	491,782	172,443	$2.37
2023	$103.3M	535,062	204,385	$2.21

5Y CAGR (cost/unit): -0.7%YoY Change (2022-2023): -6.6%

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Tacrolimus*?

In 2023, Medicare Part D spent $103.3M on Tacrolimus* (Tacrolimus), serving 204,385 beneficiaries across 535,062 claims.

What is the cost per unit of Tacrolimus* under Medicare?

The weighted average cost per dosage unit of Tacrolimus* was $2.21 in 2023. The 5-year compound annual growth rate (2019-2023) was -0.7%.

Who manufactures Tacrolimus*?

Tacrolimus* (generic name: Tacrolimus) is manufactured by Overall. There are 21 manufacturer(s) listed in the CMS database for this drug.

Is Tacrolimus* covered by Medicare Part D?

Yes, Tacrolimus* is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore More Data Tools

For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

$75.2M

372,291

119,454

$2.28

2020

$104.5M

448,510

133,950

$2.38

2021

$101.8M

468,258

155,736